Cap-dependent endonuclease inhibitors (CENis) - NHRC

Location: Texas
Posted: May 15, 2026
Due: May 25, 2026
Agency: DEPT OF DEFENSE
Type of Government: Federal
Category:
  • A - Research and development
Solicitation No: N0018926QB059
Publication URL: To access bid details, please log in.
Follow
Cap-dependent endonuclease inhibitors (CENis) - NHRC
Active
Contract Opportunity
Notice ID
N0018926QB059
Related Notice
Department/Ind. Agency
DEPT OF DEFENSE
Sub-tier
DEPT OF THE NAVY
Major Command
NAVSUP
Sub Command
NAVSUP GLOBAL LOGISTICS SUPPORT
Sub Command 2
NAVSUP FLC NORFOLK
Office
NAVSUP FLT LOG CTR NORFOLK
Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information
  • Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
  • Original Published Date: May 15, 2026 02:47 pm EDT
  • Original Date Offers Due: May 25, 2026 05:00 pm EDT
  • Inactive Policy: 15 days after date offers due
  • Original Inactive Date: Jun 09, 2026
  • Initiative:
    • None
Classification
  • Original Set Aside: No Set aside used
  • Product Service Code: AN42 - HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH
  • NAICS Code:
    • 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
  • Place of Performance:
    Galveston , TX
    USA
Description

The preclinical development of Cap-dependent endonuclease inhibitors (CENi), a class of small molecules, as broad-spectrum antiviral therapeutics. The scope of this project includes all activities required to select lead CENi candidates, including in vitro and in vivo efficacy studies and characterization and optimization of lead compounds. This includes Research Support expertise regarding the preclinical development of cap-dependent endonuclease inhibitors (CENis) with viruses that require biosafety level 4 (BSL-4) containment to support the Naval Medical Research Command in Fort Detrick, MD. This work will be performed over a 36-month period.


Attachments/Links
Contact Information
Contracting Office Address
  • ATTENTION CODE 301 1968 GILBERT STREET SUITE 600
  • NORFOLK , VA 23511-3392
  • USA
Primary Point of Contact
Secondary Point of Contact
History
  • May 15, 2026 02:47 pm EDTCombined Synopsis/Solicitation (Original)

Related Document

May 26, 2026[Combined Synopsis/Solicitation (Updated)] Cap-dependent endonuclease inhibitors (CENis) - NHRC
Daily notification on new contract opportunities

With GovernmentContracts, you can:

  • Find more opportunities and win more business
  • Receive daily alerts for all new bid opportunities
  • Get contract opportunities matched to your business
ONE WEEK FREE TRIAL

See also

Follow AIR FORCE CRYPTOLOGIC OFFICE COMMERCIAL SOLUTIONS OPENING Active Contract Opportunity Notice ID

DEPT OF DEFENSE

Bid Due: 9/30/2026

Bid Number Bid Title Bid Type Organization Bid Issue Date Bid Close Date

North East Independent School District

Bid Due: 11/30/2027

Follow F-35 JPO PRESOLICITATION NOTICE TO SOLE SOURCE: MCK Active Contract Opportunity Notice

DEPT OF DEFENSE

Bid Due: 6/18/2026

Bid Number Bid Title Bid Type Organization Bid Issue Date Bid Close Date

North East Independent School District

Bid Due: 1/05/2028

* Disclaimer: Information regarding bids, requests for proposals (RFPs), or requests for qualifications (RFQs) is provided on this website only for convenience and does not constitute official public notice. Persons wishing to respond to or inquire about bids, RFPs, or RFQs should contact the appropriate government department.